L'US Pfizer a offert 106 milliards de $ a l' UK AstraZeneca qui vient de refuser l'offre. Bayer depenserait $14 milliards pour la division sante grandpublic de Merck > Novartis,suisse , mettrait la main sur la division oncologie de GSK anglias , pour 16 milliards. Le canadien Valeant lance une OPA hostile sur Allergan, (Botox) pour $45 milliards. Les brevets de medicaments generant 1 milliard de $ de profits tombent dans le domaine public. Alors les labos cherchent la croissance externe, moins risquee que les recherches en interne. Et voici…
Read MoreDecember 23rd, 2024
Last articles
- The Right of the 1st Night and Sexual Violence against Armenian Women in the Nineteenth Century
- MIPTV, Canneseries 2024: 3 Shows You Don’t Want to Miss - 135 exhibitors attended for MIPTV this April in Cannes
- Henry Kissinger died at 100 years old
- Zarmanazan 2024: Creative and interactive Western Armenian language program
- Prime Minister Pashinyan's speech at the autumn session of the OSCE Parliamentary Assembly
